Effects of female hormones on spinal cord function
Official title: TMSpine: The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
Run by University of Texas Southwestern Medical Center · NCT06656819 · Data updated 2026-11-12
This study is testing how changes in female hormones affect the spinal cord's ability to adapt and function in healthy young women and comparing it with men.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 39 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | University of Texas Southwestern Medical Center Academic / other |
| Locations | 1 site (Dallas, Texas) |
| Status | Recruiting |
| Started | July 1, 2020 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | March 30, 2026 |
| Trial ID | NCT06656819 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy females aged 18-39 with regular menstrual cycles and moderate physical activity levels.
✕Probably not a fit
Patients with a history of spinal or neurological injuries, hormonal contraceptive use, or certain medical conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to investigate how fluctuations in estradiol levels affect spinal cord neuroplasticity in healthy young females. The study will assess spinal circuit excitability through sensory and motor priming techniques, utilizing repetitive peripheral nerve electrical stimulation. It will involve both male and female participants to compare the effects of hormonal variations on spinal motor circuits. The research seeks to enhance understanding of the role of female sex hormones in spinal cord function.
Why it matters
Potential benefit: If successful, this study could lead to improved treatments for conditions related to spinal cord function and neuroplasticity in women.
How similar studies have gone: While the specific approach may be novel, studies on the effects of sex hormones on neuroplasticity have shown promising results.
Who can join: the full rules
Show full inclusion / exclusion criteria
FEMALES Inclusion Criteria: * Ages 18-39 years * Eumenorrheic (regular monthly cycles of 24-35 days) * Moderately active (less than 7 hours of vigorous physical activity per week) * History of pregnancy is allowed if patient is in post-lactation phase Exclusion Criteria: * History of musculoskeletal or orthopedic injury of the spine, hip, knee, ankle or foot * History of neurological injury of the peripheral or central nervous system * Current smoker * History of disordered eating * History of stress fracture in the lower limb * History of a connective tissue disorder (Marfan's syndrome, Ehlers-Danlos disease) * Pacemaker, metal implants in the head and spine region * Pregnancy * On a hormonal contraceptive regimen (oral, transdermal or vaginal) * History of menstrual dysfunction (primary or secondary amenorrhea, oligomenorrhea, anovulatory cycles, polycystic ovarian disease) * Started or stopped taking oral contraceptives within the previous 6 months * Exercise vigorously more than 7 hours per week or currently participating in competitive level sports. MALES Inclusion Criteria: * Ages 18-39 * Moderately active (less than 7 hours of vigorous physical activity per week) Exclusion Criteria: * History of musculoskeletal or orthopedic injury of the spine, hip, knee, ankle or foot * History of neurological injury of the peripheral or central nervous system * Current smoker * History of disordered eating * History of stress fracture in the lower limb * History of a connective tissue disorder (Marfan's syndrome, Ehlers-Danlos disease) * Pacemaker, metal implants in the head and spine region
Where it's running
-
University of Texas Southwestern Medical Center
Dallas, Texas, United States Recruiting
Study contacts
- Principal investigator: Yasin Dhaher, Ph.D. — University of Texas Southwestern Medical Center
- Study coordinator: Yu-Chen Chung, PT, Ph.D.
- Email: yu-chen.chung@utsouthwestern.edu
- Phone: 214-648-8838
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tirzepatide for methamphetamine use disorder (phase 2)
This phase 2 trial tests whether weekly tirzepatide injections can help adults with moderate to severe methamphetamine use disorder reduce use and improve outcomes compared with placebo.
-
Do beverage cues drive craving in adults with AUD
In adults with alcohol use disorder, this study tests whether different non-alcoholic beverage cues can trigger cravings differently when people see and smell them without drinking.
-
How foot braces might help people with ataxia walk better
This study tests whether wearing foot orthoses at home can improve gait and balance for adults with cerebellar ataxia.
-
Personalized Ultrafractionated Stereotactic Radiotherapy with Perioperative FLOT for GEJ and Esophageal Cancer
This trial tests adding a personalized, ultra-fractionated radiotherapy boost (PULSAR) to standard perioperative FLOT chemotherapy for patients with esophageal or gastroesophageal junction cancer to see if it can be used safely.
-
Hemophilia A: comparing long-acting FVIII replacement vs non-FVIII therapy in kids
This study tests whether children with moderate to severe Hemophilia A on long-acting FVIII or non-FVIII therapies form clots differently and develop small joint bleeds or early joint changes.
-
Adaptive dosing of immune therapy for hepatocellular carcinoma
This trial tests whether changing the dosing schedule of nivolumab plus ipilimumab can help people with hepatocellular carcinoma who have Child-Pugh B liver disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.